Simply Wall St.85d agobearish
What Does Bristol Myers Squibb (BMY) Risk From The Revived $6.7 Billion Lawsuit?Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
102last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
InvestorsHub95d agobearish
AZN rebounds after report dismisses AstraZeneca-Bristol Myers merger speculationBarrons.com97d agobearish
Bristol Myers Squibb Stock Soars on Report of $400 Billion Merger Talks With AstraZenecaThe Wall Street Journal97d agobearish
U.S. Stock Futures Rise, Oil Falls as U.S. Shifts Toward Diplomacy with IranThe Wall Street Journal97d agobearish
AstraZeneca Shares Drop After Reports of Bristol Myers Squibb Merger TalksThe Wall Street Journal174d agobearish
Regeneron Stock Tumbles on Melanoma Drug-Trial MissThe Wall Street Journal174d agobearish
Regeneron Melanoma Drug Trial Disappoints and Shares Slide